Investigation Report on China Oxiracetam Market, 2010-2019

According to the National bureau of statistics of China, by the end of 2014, the number of Chinese aged above 60 years old is 212.42 million, occupying 15.5% of the total…
Reference: 1506197
Price: $2,000.00
Tax included

General

Publisher:
CRI
Geography Covered
China
Publication Date
6/4/2015
Pages
30
Version:
2010
Charts:
30
Language
  • English
  • Chinese
Format
License

Description

According to the National bureau of statistics of China, by the end of 2014, the number of Chinese aged above 60 years old is 212.42 million, occupying 15.5% of the total population; the number of Chinese aged above 65 is 137.55 million, occupying 10.1% of the total population. Senile dementia poses a serious threat to old people. According to statistics, about 10% of people aged above 60 suffer from senile dementia, among which 5% have Alzheimei’s Disease (AD). In China, the number of senile dementia cases is estimated to be over 10 million and the incidence of AD doubles for every 5 years of age. There are about 20% of sick old people aged between 80-85 suffer from senile dementia, which strains their families as well as the society.
Oxiracetam, a derivative of pyrrolidone, was first synthesized by ISF in 1974. It is a nootropic drug whose oral preparation and injection entered the Italian market respectively in 1987 and 1990.
Oxiracetam develops fast after entering China, annual sales rising from less than 20 million in 2005 to 1.235 billion in 2014 and CAGR reaching up to 60% during the period of 2005-2014. Oxiracetam enjoys a vast demand in China. Products from CSPC Ouyi Pharmaceutical Co., Ltd, Hunan Jianlang Pharmaceutical Co., Ltd, Harbin Medisan Pharmaceutical Co., Ltd and Guangdong SENCEE Pharmaceutical Co., Ltd all occupy certain share of the market, among which Guangdong SENCEE has the largest market share of 34.16% with sales revenue reaching up to CNY 422 million in 2014.
As the ageing of population becomes more and more serious in China, senile dementia increasingly becomes a severe social problem. The market size of oxiracetam in China is expected to keep growing in the next few years.

Readers can get at least the following information through this report:
-market share of manufacturers of oxiracetam in Chinese market
-price of oxiracetam in Chinese market
-major manufacturers of oxiracetam in China
-share of different dosage forms of oxiracetam in Chinese market
-market outlook of oxiracetam in China

The author suggests the following groups of people purchase this report:
-manufacturers of nootropic drugs
-investors/ research institutions interested in Chinese medicine market
-any interest in Chinese medicine market, please contact CRI for customized survey service
Table of Contents

1 Related Concepts of Oxiracetam
1.1 Indicaiton
1.2 Sales Status in Global Market

2 Market Profile of Oxiracetam in China
2.1 Patent and Approval Status of Oxiracetam in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Oxiracetam in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Oxiracetam in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume


5 Survey on Dosage Forms of Oxiracetam in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Oxiracetam in Chinese Hospitals in 2014
6.1 CSPC Ouyi Pharmaceutical Co., Ltd (Trade Name: Ou Lai Ning)
6.2 Hunan Jianlang Pharmaceutical Co., Ltd (Trade Name: Jian Lang Xing)
6.3 Harbin Medisan Pharmaceutical Co., Ltd (Trade Name: Ou Lan Tong)
6.4 Guangdong SENCEE Pharmaceutical Co., Ltd (Trade Name: Bei Qing Xing)

7 Major Manufacturers of Oxiracetam in the Chinese Market, 2010-2014
7.1 CSPC Ouyi Pharmaceutical Co., Ltd
7.2 Hunan Jianlang Pharmaceutical Co., Ltd
7.3 Harbin Medisan Pharmaceutical Co., Ltd
7.4 Guangdong SENCEE Pharmaceutical Co., Ltd

8 Market Outlook of Oxiracetam in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

Selected Charts
Chart Patent Status of Oxiracetam in China
Chart Approval Information of Oxiracetam in China
Chart Sales Status of Oxiracetam in China, 2010-2014
Chart Sales Value of Oxiracetam in China, 2010-2014
Chart Sales Value of Oxiracetam in Some Regions in China, 2010-2014
Chart Sales Volume of Oxiracetam in China, 2010-2014
Chart Sales Value and Market Share of Oxiracetam Made by Harbin Medisan in China, 2010-2014
Chart Sales Value and Market Share of Oxiracetam Made by Guangdong SENCEE in China, 2010-2014
Chart Sales Value and Market Share of Oxiracetam Made by Hunan Jianlang in China, 2010-2014
Chart Sales Value and Market Share of Oxiracetam Made by CSPC Ouyi in China, 2010-2014
Chart Market Share of TOP4 Manufacturers of Oxiracetam by Sales Volume in China, 2010-2014
Chart Sales Value and Market Share of Oxiracetam Injections in China, 2010-2014
Chart Sales Value and Market Share of Oxiracetam Capsules in China, 2010-2014
Chart Price of Oxiracetam Made by CSPC Ouyi Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Oxiracetam Made by Hunan Jianlang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Oxiracetam Made by Harbin Medisan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Oxiracetam Made by Guangdong SENCEE Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Scroll